Scotland · NHS Scotland MSAN
H2-antagonists (cimetidine, famotidine and nizatidine)
MSAN(2020)35 · Level 2 · issued 30 Apr 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Cimetidine 200mg tablets are back in stock with Ennogen; Medreich are out of stock with no | Out of stock | — |
| Cimetidine 400mg tablets are out of stock until March 2021 (Ennogen); Medreich are out of stock | Out of stock | March 2021 |
| Cimetidine 800mg tablets are back in stock with Ennogen; Medreich are out of stock with no | Out of stock | — |
| Nizatidine 150mg and 300mg tablets are out of stock until the end of 2020 (Mylan); Medreich are | Out of stock | the end of 2020 |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2020:35
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
79538b927d5a83d830052bf7e04d210a7dfffc0dd6bd89b3aa77d9ce731f7c23sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2020-35.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.